Search
for
Sort by
Research 31–60 of 80
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
- WARFARIN
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Ethosomes: New Prospects in Transdermal Delivery
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Long-Term Effects of COVID-19
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- COVID‐19 and cutaneous manifestations: A review of the published literature
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children
- Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- COVID-19 infection is a major cause of acute telogen effluvium
- Clinical review of ejaculatory dysfunction
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- COVID-19 and hypopituitarism
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- COVID-19 in Africa: an ovarian victory?
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
- An overview of current strategies and future prospects in drug repurposing in tuberculosis
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19